Nalmefene hydrochloride injection is an opioid antagonist indicated for the complete or partial reversal of opioid drug effects, including respiratory depression, induced by either natural or ...

Nalmefene hydrochloride 1mg/mL (equivalent to 1mg nalmefene base); per vial; soln for IV, IM, or SC inj. IV route preferable: see full labeling. Reversal of opioid effects: see full labeling.

North America & Europe Nalmefene Hydrochloride Market was valued at US$ 4.8 million in 2022 and is projected to surpass the market size of US$ 6.9 million by 2031 at a CAGR of 4.12% during the ...

The Food and Drug Administration (FDA) has approved Zurnai ™, the first nalmefene HCl autoinjector for the emergency treatment of known or suspected opioid overdose in adults an ...